Fabrication of Mucoadhesive-Dendrimers as Solid Dosage Forms

  • Nidhi Raval
  • Rahul Maheshwari
  • Kiran Kalia
  • Rakesh Kumar Tekade
Part of the Methods in Molecular Biology book series (MIMB, volume 2000)


Mucoadhesion has a potential role in the delivery of pharmaceutical medicaments via various routes of administration, viz. oral, nasal, vaginal, and buccal. Mucoadhesion provides controlled drug delivery, sustained drug delivery, and local or site-specific drug delivery. This chapter focuses on the mechanism of bio-adhesion to glycoprotein layer of mucosal membrane. Some of the gastric mucoadhesive solid dosage forms of nanocarrier, viz. nanoparticle, microsphere, and nanofibers, undergo evaluation of mucoadhesive parameters. That includes mucoadhesive strength, tensile strength, swelling index, stability studies, in vivo study, etc. The oral route is the most desirable way among intravenous, subcutaneous, intramuscular, intranasal, intravaginal, etc. for drug delivery and because of patient compliance. One of the novel approaches is where nanocarrier is loaded in the solid dosage form for effective drug action and enhanced local delivery of a drug. Mainly this chapter explains about dendrimer-based oral solid dosage form (tablet) employing mucoadhesive polymers with an aim to improve retention time of drug at desired sites. Dendrimer-loaded mucoadhesive tablets promise controlled drug delivery with a gastro-retentive property, higher drug incorporation, ease of formulation development, and accessible absorption, owing to adjacent interaction with a biological membrane and prolonged retention to mucosa providing higher bioavailability of drugs.

Key words

Mucoadhesive dosage form Biological membrane Controlled drug delivery Dendrimer Tablets Gastro-retentive property 



The author RKT would like to acknowledge Science and Engineering Research Board (Statutory Body Established Through an Act of Parliament: SERB Act 2008), Department of Science and Technology, Government of India, for the award of early carrier research grant (File Number: ECR/2016/001964) and DST-NPDF to Dr. Maheshwari (PDF/2016/003329) in Dr. Tekades’s lab. Authors would also like to thank NIPER-Ahmedabad for providing research support for research on cancer and arthritis.


  1. 1.
    Tiwari G, Tiwari R, Sriwastawa B et al (2012) Drug delivery systems: an updated review. Int J Pharm Investig 2(1):2CrossRefGoogle Scholar
  2. 2.
    Maheshwari R, Tekade M, Sharma PA et al (2015) Nanocarriers assisted siRNA gene therapy for the management of cardiovascular disorders. Curr Pharm Des 21(30):4427–4440CrossRefGoogle Scholar
  3. 3.
    Sharma PA, Maheshwari R, Tekade M et al (2015) Nanomaterial based approaches for the diagnosis and therapy of cardiovascular diseases. Curr Pharm Des 21(30):4465–4478CrossRefGoogle Scholar
  4. 4.
    Tekade RK, Maheshwari R, Soni N et al (2017) Nanotechnology for the development of nanomedicine. In: Nanotechnology-based approaches for targeting and delivery of drugs and genes, p. 1CrossRefGoogle Scholar
  5. 5.
    Tekade RK, Maheshwari R, Soni N et al (2017) Carbon nanotubes in targeting and delivery of drugs. In: Nanotechnology-based approaches for targeting and delivery of drugs and genes, p. 389CrossRefGoogle Scholar
  6. 6.
    Lalu L, Tambe V, Pradhan D et al (2017) Novel nanosystems for the treatment of ocular inflammation: current paradigms and future research directions. J Control Release 268:19–39CrossRefGoogle Scholar
  7. 7.
    Maheshwari RG, Tekade RK, Sharma PA et al (2012) Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: a comparative assessment. Saudi Pharm J 20(2):161–170CrossRefGoogle Scholar
  8. 8.
    Maheshwari RG, Thakur S, Singhal S et al (2015) Chitosan encrusted nonionic surfactant based vesicular formulation for topical administration of ofloxacin. Sci Adv Mater 7(6):1163–1176CrossRefGoogle Scholar
  9. 9.
    Boddupalli BM, Mohammed ZN, Nath RA et al (2010) Mucoadhesive drug delivery system: an overview. J Adv Pharm Technol Res 1(4):381CrossRefGoogle Scholar
  10. 10.
    Wang X, Li S, Shi Y et al (2014) The development of site-specific drug delivery nanocarriers based on receptor mediation. J Control Release 193:139–153CrossRefGoogle Scholar
  11. 11.
    Zaman M, Qureshi J, Ejaz H et al (2016) Oral controlled release drug delivery system and characterization of oral tablets; a review. Pak J Pharm Res 2(1):67–76CrossRefGoogle Scholar
  12. 12.
    Bandari S, Mittapalli RK, Gannu R (2014) Orodispersible tablets: an overview. Asian J Pharma 2(1)Google Scholar
  13. 13.
    Rahul M, Piyoosh S, Tekade M et al (2017) Microsponge embedded tablet for sustained delivery of nifedipine. Pharm NanotechnolGoogle Scholar
  14. 14.
    Fujihara K (2017) Pharmaceutical composition, Google PatentsGoogle Scholar
  15. 15.
    Ngwuluka NC, Choonara YE, Kumar P et al (2015) A novel pH-responsive interpolyelectrolyte hydrogel complex for the oral delivery of levodopa. Part II: characterization and formulation of an IPEC-based tablet matrix. J Biomed Mater Res A 103(3):1085–1094CrossRefGoogle Scholar
  16. 16.
    Dudhat SM, Kettler CN, Dave RH (2017) To study capping or lamination tendency of tablets through evaluation of powder rheological properties and tablet mechanical properties of directly compressible blends. AAPS PharmSciTech 18(4):1177–1189CrossRefGoogle Scholar
  17. 17.
    M. P. Ratnaparkhi, G. Mohanta and L. Upadhyay (2015) Review on: fast dissolving tablet. J Pharm Res 5–12Google Scholar
  18. 18.
    Asif F, Sultana T, Sohel MD et al (2014) In vitro dissolution pattern of metronidazole film coated tablet in presence of fruit juice. Am J Pharm Sci 2(2):32–36Google Scholar
  19. 19.
    Sakata Y, Higuchi M (2014) Sugar-coated preparation and production method for the same, Google PatentsGoogle Scholar
  20. 20.
    Meng-Lund E, Jacobsen J, Müllertz A et al (2016) Buccal absorption of diazepam is improved when administered in bioadhesive tablets—an in vivo study in conscious Göttingen mini-pigs. Int J Pharm 515(1):125–131CrossRefGoogle Scholar
  21. 21.
    Abbas R, Palumbo D, Walters F et al (2016) Single-dose pharmacokinetic properties and relative bioavailability of a novel methylphenidate extended-release chewable tablet compared with immediate-release methylphenidate chewable tablet. Clin Ther 38(5):1151–1157CrossRefGoogle Scholar
  22. 22.
    Mohammed KAB, Ibrahim HK, Ghorab MM (2016) Effervescent tablet formulation for enhanced patient compliance and the therapeutic effect of risperidone. Drug Deliv 23(1):297–306CrossRefGoogle Scholar
  23. 23.
    McConville C, Major I, Devlin B et al (2016) Development of a multi-layered vaginal tablet containing dapivirine, levonorgestrel and acyclovir for use as a multipurpose prevention technology. Eur J Pharm Biopharm 104:171–179CrossRefGoogle Scholar
  24. 24.
    Takeuchi H, Thongborisute J, Matsui Y et al (2005) Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems. Adv Drug Deliv Rev 57(11):1583–1594CrossRefGoogle Scholar
  25. 25.
    Maheshwari R, Tekade M, Gondaliya P et al (2017) Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers. Nanomedicine (Lond) 12(21):2653–2675CrossRefGoogle Scholar
  26. 26.
    Soni N, Soni N, Pandey H et al (2016) Augmented delivery of gemcitabine in lung cancer cells exploring mannose anchored solid lipid nanoparticles. J Colloid Interface Sci 481:107–116CrossRefGoogle Scholar
  27. 27.
    Tekade RK, Maheshwari R, Tekade M et al (2017) Chapter 8 - solid lipid nanoparticles for targeting and delivery of drugs and genes A2. In: Vijay M, Kesharwani P, Amin MCIM, Iyer A (eds) Nanotechnology-based approaches for targeting and delivery of drugs and genes. Academic Press, pp 256–286CrossRefGoogle Scholar
  28. 28.
    Smart JD (2005) The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev 57(11):1556–1568CrossRefGoogle Scholar
  29. 29.
    Parayath NN, Nehoff H, Taurin S et al (2016) Prospects of nanocarriers for oral delivery of bioactives using targeting strategies. Curr Pharm Biotechnol 17(8):683–699CrossRefGoogle Scholar
  30. 30.
    Sosnik A, das Neves J, Sarmento B (2014) Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: a review. Prog Polym Sci 39(12):2030–2075CrossRefGoogle Scholar
  31. 31.
    Raval N, Khunt D, Misra M (2018) Microemulsion based delivery of triamcinolone acetonide to posterior segment of eye using chitosan and butter oil as permeation enhancer: an in vitro and in vivo investigation. J Microencapsul (just-accepted):1–37Google Scholar
  32. 32.
    Gonçalves IC, Henriques PC, Seabra CL et al (2014) The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection. Expert Rev Anti-Infect Ther 12(8):981–992CrossRefGoogle Scholar
  33. 33.
    Bhalekar MR, Bargaje RV, Upadhaya PG et al (2016) Formulation of mucoadhesive gastric retentive drug delivery using thiolated xyloglucan. Carbohydr Polym 136:537–542CrossRefGoogle Scholar
  34. 34.
    Yandrapu SK, Kanujia P, Chalasani KB et al (2013) Development and optimization of thiolated dendrimer as a viable mucoadhesive excipient for the controlled drug delivery: an acyclovir model formulation. Nanomedicine 9(4):514–522CrossRefGoogle Scholar
  35. 35.
    Dwivedi N, Shah J, Mishra V et al (2016) Dendrimer-mediated approaches for the treatment of brain tumor. J Biomater Sci Polym Ed 27(7):557–580CrossRefGoogle Scholar
  36. 36.
    Gupta U, Agashe HB, Asthana A et al (2006) Dendrimers: novel polymeric nanoarchitectures for solubility enhancement. Biomacromolecules 7(3):649–658CrossRefGoogle Scholar
  37. 37.
    Tambe V, Thakkar S, Raval N et al (2017) Surface engineered Dendrimers in siRNA delivery and gene silencing. Curr Pharm Des 23(20):2952–2975CrossRefGoogle Scholar
  38. 38.
    Liao H, Liu H, Li Y et al (2014) Antitumor efficacy of doxorubicin encapsulated within PEGylated poly (amidoamine) dendrimers. J Appl Polym Sci 131(11)CrossRefGoogle Scholar
  39. 39.
    Yan C, Gu J, Lv Y et al (2017) Improved intestinal absorption of water-soluble drugs by acetylation of G2 PAMAM dendrimer nanocomplexes in rat. Drug Deliv Transl Res 3(7):408–415CrossRefGoogle Scholar
  40. 40.
    Roy R, Shiao TC (2015) Glyconanosynthons as powerful scaffolds and building blocks for the rapid construction of multifaceted, dense and chiral dendrimers. Chem Soc Rev 44(12):3924–3941CrossRefGoogle Scholar
  41. 41.
    Duncan R, Izzo L (2005) Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev 57(15):2215–2237CrossRefGoogle Scholar
  42. 42.
    Jain K, Kesharwani P, Gupta U et al (2010) Dendrimer toxicity: let’s meet the challenge. Int J Pharm 394(1):122–142CrossRefGoogle Scholar
  43. 43.
    Mansuri S, Kesharwani P, Tekade RK et al (2016) Lyophilized mucoadhesive-dendrimer enclosed matrix tablet for extended oral delivery of albendazole. Eur J Pharm Biopharm 102:202–213CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Nidhi Raval
    • 1
  • Rahul Maheshwari
    • 1
  • Kiran Kalia
    • 1
  • Rakesh Kumar Tekade
    • 1
  1. 1.Department of Pharmaceuticals, Ministry of Chemicals and FertilizersNational Institute of Pharmaceutical Education and Research (NIPER)–Ahmedabad, An Institute of National Importance, Government of IndiaGandhinagarIndia

Personalised recommendations